X hits on this document

46 views

0 shares

0 downloads

0 comments

18 / 19

Mark S. Luer, Pharm.D. page 18

Intramural 16. Inhibition of the L-amino Acid Transport System as a New Mechanism of Antiepileptic Activity. Campus Research Board (CRB), University of Illinois. Principal Investigator, July 1995. $14,509

UNIVERSITY OF KENTUCKY Extramural

  • 17.

    The Effects of rhigf-1 on Immune Response in Acute Head Injury. American College of Clinical Pharmacy; Amgen Biotechnology Research Award. Co-Investigator, February 1993. $10,000

  • 18.

    Pharmacodynamic Influences on Phenytoin Disposition during the Acute Phase Response Following Neurosurgery. Epilepsy Foundation of America. Co-Investigator, August 1992. $30,000

    • XVI.

      GRANT/CONTRACT ACTIVITY (Pending):

None

XVII. GRANT/CONTRACT ACTIVITY (Not Funded):

UNIVERSITY OF ARKANSAS

  • 1.

    Hypertonic Antioxidative Fluid Resuscitation of Combined Traumatic Head Injury. Department of Defense, Office of Naval Research. Principal Investigator, April 2002 – June 2005. $609,729 ($406,486-ONR, $203,243-State of AR; Indirect Costs: $172,377) (submitted July 2001)

  • 2.

    The Role of Blood-Brain Barrier P-glycoprotein in Limiting Antiepileptic Drug Activity. Rockefeller Brothers Fund – Charles E. Culpeper Biomedical Pilot Initiative. Co-Investigator. (Principal Investigator: Kathryn Neill, Pharm.D.) $25,000 (submitted December 2000)

  • 3.

    Pharmacokinetic/Pharmacodynamic Evaluation of P-glycoprotein Influence on Antiepileptic Drugs. Epilepsy Foundation. Research Training Fellowship. Kathryn Neill – Fellow. Submitted November 2000. $40,000

  • 4.

    Fluid Resuscitation in Combined Hemorrhagic Shock and Traumatic Brain Injury. Department of Defense, Office of Naval Research. Principal Investigator, July 2001 – June 2004. $587,005 ($391,337-ONR, $195,668-State of AR; Indirect Costs: $165,217) (submitted September

2000)

  • 5.

    Age-related Changes in Blood-Brain Barrier P-Glycoprotein Function. University of Arkansas for Medical Sciences, Reynold’s Center on Aging. Principal Investigator, submitted December

    • 1997.

      $14,988.26

  • 6.

    The Role of Blood-Brain Barrier P-Glycoprotein in Refractory Epilepsy. Klingenstein Fellowship Awards in the Neurosciences. Klingenstein Foundation. Principal Investigator, submitted December 1997. $120,000

UNIVERSITY OF ILLINOIS

  • 7.

    Microdialysis with Integrated Chemical Sensors. Campus Research Board (CRB). Co-Principal Investigator, submitted March 1996. $25,000

  • 8.

    Proposal to Establish a Computational Neuroscience Collaboratory at the University of Illinois at Chicago. Office of Neuroscience Coordination. Co-Investigator, February 1996. $1,045,238

  • 9.

    Miniature Integrated Chemical Analysis Instrumentation. National Science Foundation (NSF). Co-Principal Investigator, submitted January 1996. $483,412

  • 10.

    Gabapentin: Actions on Anticonvulsant Activity and Glutamate Disposition. AACP Young Investigators Award. Principal Investigator, submitted June 1995. $10,000

  • 11.

    Pharmacokinetics and Cerebral Hemodynamics of Acetazolamide. ACCP Research Institute, Bristol-Myers Squibb Central Nervous System Research Award. Principal Investigator, submitted February 1995. $10,000

  • 12.

    Pharmacokinetics and Cerebral Hemodynamics of Acetazolamide. AACP Young Investigators Award. Principal Investigator, submitted August 1994. $7,500

  • 13.

    The Effect of Felbamate on Caffeine Metabolism and Neurotoxicity. Wallace Laboratories. Principal Investigator, submitted July 1994. $60,097.50

Document info
Document views46
Page views46
Page last viewedThu Dec 08 02:19:42 UTC 2016
Pages19
Paragraphs522
Words6688

Comments